These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2587530)

  • 21. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
    Clemmons DR; Van Wyk JJ; Ridgway EC; Kliman B; Kjellberg RN; Underwood LE
    N Engl J Med; 1979 Nov; 301(21):1138-42. PubMed ID: 492275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of growth hormone-releasing factor on growth hormone secretion in acromegaly.
    Gelato MC; Merriam GR; Vance ML; Goldman JA; Webb C; Evans WS; Rock J; Oldfield EH; Molitch ME; Rivier J
    J Clin Endocrinol Metab; 1985 Feb; 60(2):251-7. PubMed ID: 3917454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of acromegaly and response to cryohypophysectomy.
    Hofeldt FD; Levin SR; Schneider V; Becker N; Forsham P
    Rocky Mt Med J; 1973 Aug; 70(8):21-4. PubMed ID: 4727190
    [No Abstract]   [Full Text] [Related]  

  • 25. Diagnostic utility of serum GH, IGF-1 and IGFBP3 in patients of acromegaly with uncontrolled diabetes: a pilot study.
    Dutta P; Singhal S; Sachdeva NK; Shah VN; Pathak A; Mukherjee KK; Bhansali A
    J Assoc Physicians India; 2014 Aug; 62(8):686-90. PubMed ID: 25856936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of acromegaly].
    Althoff PH; Rau H; Schmidt K; Usadel KH
    Dtsch Med Wochenschr; 1991 Jun; 116(24):941-4. PubMed ID: 2044462
    [No Abstract]   [Full Text] [Related]  

  • 27. [Acromegaly. I. Diagnostic use of radioimmunological determination of the somatotropic hormone].
    Marek J; Srámková J; Bleha O; Engelberth O
    Cas Lek Cesk; 1973; 112(24):745-50. PubMed ID: 4714502
    [No Abstract]   [Full Text] [Related]  

  • 28. Signs and symptoms of acromegaly at diagnosis: the physician's and the patient's perspectives in the ACRO-POLIS study.
    Caron P; Brue T; Raverot G; Tabarin A; Cailleux A; Delemer B; Renoult PP; Houchard A; Elaraki F; Chanson P
    Endocrine; 2019 Jan; 63(1):120-129. PubMed ID: 30269264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations of acromegaly.
    Molitch ME
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):597-614. PubMed ID: 1521514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acromegaly with 'normal' serum growth hormone levels. Clinical features, diagnosis and results of transsphenoidal microsurgery.
    Brockmeier SJ; Buchfelder M; Adams EF; Schott W; Fahlbusch R
    Horm Metab Res; 1992 Aug; 24(8):392-400. PubMed ID: 1526628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
    Felt V; Nedvídková J
    Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
    [No Abstract]   [Full Text] [Related]  

  • 32. Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly.
    Wass JA
    J Endocrinol; 1997 Oct; 155 Suppl 1():S17-9; discussion S21. PubMed ID: 9389991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous burned-out acromegaly with preservation of normal human growth hormone responses: diagnostic, historical, theoretical, and treatment aspects.
    Ewer RW; Kotheimer TG
    Johns Hopkins Med J; 1970 Oct; 127(4):199-212. PubMed ID: 4320105
    [No Abstract]   [Full Text] [Related]  

  • 34. Heel pad thickness in acromegaly.
    Kho KM; Wright AD; Doyle FH
    Br J Radiol; 1970 Feb; 43(506):119-25. PubMed ID: 5424277
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
    Mazziotti G; Bonadonna S; Doga M; Patelli I; Gazzaruso C; Solerte SB; De Menis E; Giustina A
    Neuroendocrinology; 2008; 88(4):299-304. PubMed ID: 18617732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiogrammetry of the soft tissue at the index finger in acromegaly.
    Dequeker J; Geussens P; De Proft G; Bouillon R
    Clin Radiol; 1979 Sep; 30(5):517-9. PubMed ID: 466955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isodensigraphic contribution to X-ray diagnosis of acromegaly (author's transl)].
    Balcar V; Silinková-Málková E; Marek J; Pacovský V
    Sb Lek; 1977 Aug; 79(7-8):223-5. PubMed ID: 905760
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
    Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acromegaly and pregnancy].
    Andreeva M; Tomova A; Shterev A
    Vutr Boles; 1990; 29(1):94-9. PubMed ID: 2396422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.